Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00671801
What this trial is testing

Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I

Who this might be right for
Malignant Gliomas
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Ended earlyNCT02465528
What this trial is testing

Ceritinib Rare Indications Study in ALK+ Tumors

Who this might be right for
Tumors With Aberrations in ALKAnaplastic Large Cell LymphomaInflammatory Myofibroblastic Tumor+1 more
Novartis Pharmaceuticals 22
Testing effectiveness (Phase 2)Ended earlyNCT05563272
What this trial is testing

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Who this might be right for
Cervical CancerColorectal CancerEsophageal Cancer+16 more
Telix Pharmaceuticals (Innovations) Pty Ltd 11
Early research (Phase 1)Looking for participantsNCT05083754
What this trial is testing

Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Early research (Phase 1)Study completedNCT00003022
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more
Memorial Sloan Kettering Cancer Center
Not applicableEnrolling By InvitationNCT05116137
What this trial is testing

The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors

Who this might be right for
Glioblastoma Multiforme of BrainBrain Cancer
Nova Scotia Health Authority 24
Testing effectiveness (Phase 2)Study completedNCT00919737
What this trial is testing

Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme

Who this might be right for
Malignant Glioma
Nobelpharma 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05053880
What this trial is testing

Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma Multiforme(GBM)
Accendatech USA Inc. 48
Testing effectiveness (Phase 2)Study completedNCT02337491
What this trial is testing

Pembrolizumab +/- Bevacizumab for Recurrent GBM

Who this might be right for
Glioblastoma
Dana-Farber Cancer Institute 80
Early research (Phase 1)Ended earlyNCT00895960
What this trial is testing

Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma

Who this might be right for
GlioblastomaCNS DiseaseBrain Diseases
M.D. Anderson Cancer Center 16
Early research (Phase 1)Study completedNCT00821080
What this trial is testing

Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Massachusetts General Hospital 33
Not applicableStudy completedNCT04822688
What this trial is testing

Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues

Who this might be right for
GlioblastomaMalignant Solid Neoplasm
Thomas Jefferson University 141
Early research (Phase 1)Active Not RecruitingNCT06894979
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Who this might be right for
Childhood AstrocytomaChildhood Diffuse Intrinsic Pontine GliomaChildhood Diffuse Midline Glioma+2 more
Children's Oncology Group 54
Early research (Phase 1)Ended earlyNCT04541225
What this trial is testing

Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors

Who this might be right for
GliomaGlioma, MalignantGlioma, Mixed+21 more
Nuvation Bio Inc. 74
Testing effectiveness (Phase 2)Study completedNCT02661282
What this trial is testing

Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma

Who this might be right for
Cytomegalovirus PositiveGlioblastomaGliosarcoma+3 more
M.D. Anderson Cancer Center 65
Testing effectiveness (Phase 2)Study completedNCT03216499
What this trial is testing

HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Testing effectiveness (Phase 2)WithdrawnNCT04482933
What this trial is testing

HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma

Who this might be right for
NeoplasmsHigh Grade GliomaGlioblastoma Multiforme+5 more
Pediatric Brain Tumor Consortium
Testing effectiveness (Phase 2)Study completedNCT00003176
What this trial is testing

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 82
Not applicableStudy completedNCT03997617
What this trial is testing

Personalized Functional Profiling in Metastatic Gastrointestinal Cancer or Recurrent Glioblastoma Patients in Luxembourg.

Who this might be right for
Oncology
Luxembourg Institute of Health 57
Early research (Phase 1)Study completedNCT01273090
What this trial is testing

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+2 more
Children's Oncology Group 34
Next Page